Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDPH.L Regulatory News (DPH)

  • There is currently no data for DPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Dechra Pharmaceuticals plc

15 Dec 2023 09:20

RNS Number : 9829W
Societe Generale SA
15 December 2023

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Full name of discloser:

SOCIETE GENERALE SA

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor, and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Dechra Pharmaceuticals plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

14/12/2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

1p ordinary

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

6,371,992

5.59

1,600

0.00

(2) Cash-settled derivatives:

0

0.00

4,659,769

4.09

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00

0

0.00

TOTAL:

6,371,992

5.59

4,661,369

4.09

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

GBP

1p ordinary

Purchase

219

38.46

1p ordinary

Purchase

439

38.46

1p ordinary

Purchase

439

38.46

1p ordinary

Purchase

439

38.46

1p ordinary

Purchase

9

38.42

1p ordinary

Purchase

37

38.44

1p ordinary

Purchase

57

38.46

1p ordinary

Purchase

58

38.44

1p ordinary

Purchase

66

38.48

1p ordinary

Purchase

101

38.5

1p ordinary

Purchase

105

38.44

1p ordinary

Purchase

146

38.42

1p ordinary

Purchase

200

38.42

1p ordinary

Purchase

200

38.48

1p ordinary

Purchase

230

38.44

1p ordinary

Purchase

261

38.44

1p ordinary

Purchase

300

38.42

1p ordinary

Purchase

302

38.44

1p ordinary

Purchase

733

38.44

1p ordinary

Purchase

800

38.42

1p ordinary

Purchase

113

38.46

1p ordinary

Purchase

120

38.46

1p ordinary

Purchase

1,200

38.46

1p ordinary

Purchase

3

38.46

1p ordinary

Purchase

3

38.46

1p ordinary

Purchase

5

38.46

1p ordinary

Purchase

26

38.46

1p ordinary

Purchase

30

38.46

1p ordinary

Purchase

97

38.46

1p ordinary

Purchase

123

38.46

1p ordinary

Purchase

133

38.46

1p ordinary

Purchase

180

38.46

1p ordinary

Purchase

224

38.46

1p ordinary

Purchase

233

38.46

1p ordinary

Purchase

265

38.46

1p ordinary

Purchase

316

38.46

1p ordinary

Purchase

371

38.46

1p ordinary

Purchase

424

38.46

1p ordinary

Purchase

439

38.46

1p ordinary

Purchase

439

38.46

1p ordinary

Purchase

439

38.46

1p ordinary

Purchase

460

38.46

1p ordinary

Purchase

471

38.46

1p ordinary

Purchase

474

38.46

1p ordinary

Purchase

483

38.46

1p ordinary

Purchase

488

38.46

1p ordinary

Purchase

659

38.46

1p ordinary

Purchase

1,031

38.46

1p ordinary

Purchase

1,090

38.46

1p ordinary

Purchase

1,141

38.46

1p ordinary

Purchase

1,215

38.46

1p ordinary

Purchase

1,245

38.46

1p ordinary

Purchase

1,589

38.46

1p ordinary

Purchase

1,916

38.46

1p ordinary

Purchase

2,024

38.46

1p ordinary

Purchase

2,062

38.46

1p ordinary

Purchase

3,102

38.46

1p ordinary

Purchase

3,435

38.46

1p ordinary

Purchase

14,042

38.46

1p ordinary

Purchase

2,414

38.46

1p ordinary

Purchase

10

38.42

1p ordinary

Purchase

38

38.42

1p ordinary

Purchase

347

38.42

1p ordinary

Purchase

1,485

38.42

1p ordinary

Purchase

1,529

38.44

1p ordinary

Purchase

20

38.42

1p ordinary

Purchase

229

38.42

1p ordinary

Purchase

3

38.44

1p ordinary

Purchase

8

38.42

1p ordinary

Purchase

10

38.44

1p ordinary

Purchase

12

38.44

14

38.44

1p ordinary

Purchase

30

38.44

1p ordinary

Purchase

32

38.44

1p ordinary

Purchase

39

38.44

1p ordinary

Purchase

41

38.44

1p ordinary

Purchase

49

38.44

1p ordinary

Purchase

50

38.44

1p ordinary

Purchase

52

38.44

1p ordinary

Purchase

52

38.44

1p ordinary

Purchase

52

38.44

1p ordinary

Purchase

53

38.44

1p ordinary

Purchase

53

38.44

1p ordinary

Purchase

53

38.44

1p ordinary

Purchase

53

38.44

1p ordinary

Purchase

53

38.44

1p ordinary

Purchase

53

38.44

1p ordinary

Purchase

53

38.44

1p ordinary

Purchase

56

38.44

1p ordinary

Purchase

69

38.44

1p ordinary

Purchase

75

38.44

1p ordinary

Purchase

99

38.44

1p ordinary

Purchase

120

38.42

1p ordinary

Purchase

122

38.42

1p ordinary

Purchase

131

38.44

1p ordinary

Purchase

140

38.42

1p ordinary

Purchase

150

38.44

1p ordinary

Purchase

194

38.44

1p ordinary

Purchase

203

38.44

1p ordinary

Purchase

300

38.42

1p ordinary

Purchase

300

38.44

1p ordinary

Purchase

306

38.44

1p ordinary

Purchase

313

38.44

1p ordinary

Purchase

355

38.44

1p ordinary

Purchase

631

38.42

1p ordinary

Purchase

763

38.44

1p ordinary

Purchase

800

38.44

1p ordinary

Purchase

1,000

38.44

1p ordinary

Purchase

1,051

38.42

1p ordinary

Purchase

1,091

38.44

1p ordinary

Purchase

1,323

38.42

1p ordinary

Sale

439

38.46

1p ordinary

Sale

4,386

38.44087

1p ordinary

Sale

439

38.46

1p ordinary

Sale

10,964

38.4559

1p ordinary

Sale

439

38.46

1p ordinary

Sale

21,929

38.44632

1p ordinary

Sale

123

38.46

1p ordinary

Sale

8,772

38.44321

1p ordinary

Sale

316

38.46

1p ordinary

Sale

20

38.4

1p ordinary

Sale

20

38.4

1p ordinary

Sale

20

38.4

1p ordinary

Sale

20

38.4

1p ordinary

Sale

30

38.4

1p ordinary

Sale

67

38.42

1p ordinary

Sale

86

38.44

1p ordinary

Sale

112

38.4

1p ordinary

Sale

144

38.4

1p ordinary

Sale

158

38.4

1p ordinary

Sale

242

38.42

1p ordinary

Sale

351

38.4

1p ordinary

Sale

411

38.44

1p ordinary

Sale

121

38.42

1p ordinary

Sale

200

38.42

1p ordinary

Sale

520

38.44

1p ordinary

Sale

51

38.42

1p ordinary

Sale

513

38.4

1p ordinary

Sale

95

38.54

1p ordinary

Sale

122

38.42

1p ordinary

Sale

144

38.4

1p ordinary

Sale

152

38.42

1p ordinary

Sale

234

38.4

1p ordinary

Sale

318

38.4

1p ordinary

Sale

414

38.42

1p ordinary

Sale

428

38.46

1p ordinary

Sale

471

38.4

1p ordinary

Sale

659

38.46

1p ordinary

Sale

1,322

38.42

1p ordinary

Sale

1,323

38.42

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

GBP

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

15/12/2023

Contact name:

Paul Jenkins

Telephone number:

+44 20 7676 6969

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RETGCBDDRBBDGXU
Date   Source Headline
16th Jan 20244:54 pmRNSHolding(s) in Company
16th Jan 20243:29 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20242:43 pmRNSHolding(s) in Company
16th Jan 20241:25 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20241:15 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20241:02 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
16th Jan 202412:50 pmRNSForm 8.5 (EPT/RI)-Replacement of Dechra
16th Jan 202412:44 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 202412:04 pmRNSHolding(s) in Company
16th Jan 202410:15 amRNSScheme of Arrangement becomes Effective
16th Jan 202410:11 amRNSForm 8.5 (EPT/NON-RI) - Dechra Pharmaceuticals PLC
16th Jan 202410:11 amRNSForm 8.5 (EPT/RI)
16th Jan 20249:20 amRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20249:04 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
16th Jan 20249:00 amRNSHolding(s) in Company
16th Jan 20248:12 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Plc
16th Jan 20247:39 amGNWForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc
16th Jan 20247:30 amRNSSuspension - Dechra Pharmaceuticals PLC
15th Jan 20244:51 pmRNSDirector/PDMR Shareholding
15th Jan 20243:51 pmRNSHolding(s) in Company
15th Jan 20243:30 pmGNWForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20243:20 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20243:03 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20241:57 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20241:46 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
15th Jan 202412:35 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
15th Jan 202412:05 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 202411:51 amRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 202411:25 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Plc
15th Jan 20249:58 amRNSForm 8.5 (EPT/NON-RI)
15th Jan 20249:58 amRNSForm 8.5 (EPT/RI)
15th Jan 20249:31 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
15th Jan 20249:13 amRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20247:29 amGNWForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc
12th Jan 20244:02 pmRNSCourt sanction of Scheme of Arrangement
12th Jan 20243:30 pmGNWForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20243:20 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20243:07 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20242:42 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20242:30 pmRNSHolding(s) in Company
12th Jan 20241:38 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
12th Jan 20241:24 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 202412:03 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 202410:39 amGNWForm 8.3 - Dechra Pharmaceuticals PLC
12th Jan 202410:39 amRNSForm 8.5 (EPT/RI)
12th Jan 202410:36 amRNSForm 8.5 (EPT/NON-RI)
12th Jan 202410:35 amRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20249:34 amRNSHolding(s) in Company
12th Jan 20249:22 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
12th Jan 20248:09 amGNWForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.